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ABSTRACT
Objectives: To inform the rational deployment of
assessor resource in the evaluation of applications to
the UK Advisory Committee on Clinical Excellence
Awards (ACCEA).
Setting: ACCEA are responsible for a scheme to
financially reward senior doctors in England and Wales
who are assessed to be working over and above the
standard expected of their role.
Participants: Anonymised applications of consultants
and senior academic GPs for awards were considered
by members of 14 regional subcommittees and 2
national assessing committees during the 2014–2015
round of applications.
Design: It involved secondary analysis of complete
anonymised national data set.
Primary and secondary outcome measures: We
analysed scores for each of 1916 applications for a
clinical excellence award across 4 levels of award.
Scores were provided by members of 16
subcommittees. We assessed the reliability of
assessments and described the variance in the
assessment of scores.
Results: Members of regional subcommittees
assessed 1529 new applications and 387 renewal
applications. Average scores increased with the level of
application being made. On average, applications were
assessed by 9.5 assessors. The highest contributions
to the variance in individual assessors’ assessments of
applications were attributable to assessors or to
residual variance. The applicant accounted for around a
quarter of the variance in scores for new bronze
applications, with this proportion decreasing for higher
award levels. Reliability in excess of 0.7 can be
attained where 4 assessors score bronze applications,
with twice as many assessors being required for higher
levels of application.
Conclusions: Assessment processes pertaining in the
competitive allocation of public funds need to be
credible and efficient. The present arrangements for
assessing and scoring applications are defensible,
depending on the level of reliability judged to be
required in the assessment process. Some relatively
minor reconfiguration in approaches to scoring might
usefully be considered in future rounds of assessment.
BACKGROUND
The UK Clinical Excellence Awards
Scheme recognises and rewards National
Health Service (NHS) consultants and senior
academic GPs who perform over and above
the standard expected of their role. It is
managed and overseen by the Advisory
Committee on Clinical Excellence Awards
(ACCEA).1 The scheme recognises 12 levels
of award—from local awards considered and
awarded using a local process, through to
nationally assessed and awarded bronze,
silver, gold and platinum awards. Awards are
associated with an increasing scale of monet-
ary payments. New applications are assessed
on the basis of individuals providing evi-
dence of performance demonstrating sus-
tained commitment to patient care and
public health; high standards of clinical care,
and commitment to the values and goals of
the NHS.
Assessors consider applications guided by
the principles of equity, transparency and
value for money. ACCEA is a UK non-
departmental public body. The Committee
advises government ministers on award
Strengths and limitations of this study
▪ First comprehensive published analysis of the
reliability of the assessment processes used to
evaluate applications from UK senior doctors for
clinical excellence awards.
▪ Used comprehensive national data drawn from
all of the 16 subcommittees assessing applica-
tions in the UK from the most recent completed
round of applications (2014–2015).
▪ Quantified variances from a number of sources
contributing to the assessments.
▪ Assumed the assessor variance to be constant
across different types of assessor.
▪ Assumed that the assessor variances are con-
stant across committees.
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nominations. Applications for national level awards are
assessed by the members of 1 of 14 regionally distributed
subcommittees and from 2 national committees.
Subcommittee membership is drawn from a wide range
of professional, lay and NHS management (employer)
backgrounds. Subcommittee members assess applica-
tions, identifying a shortlist of ranked nominees, which
are then submitted for consideration to the main
national ACCEA committee. In making their recommen-
dations to ministers, ACCEA also considers doctors who
have been shortlisted by a range of accredited national
nominating bodies. Each application covers ﬁve domains
of professional activity (service delivery, development,
leadership, research and innovation, training), an
outline of the doctor’s job plan and a personal state-
ment submitted by the doctor. Applications are submit-
ted using an online process, which are assessed against
strictly deﬁned criteria (table 1) using a four-point
scoring system in which each of the ﬁve domains of the
application is awarded a score of 0, 2, 6 or 10 points. An
overall average score is derived for each domain for each
applicant and is used to rank applicants on a percentile
basis.
Various safeguards are built in to the assessment process
with a view to ensuring a rigorous, fair and scientiﬁcally
defensible outcome. Applications may be supported by a
short citation submitted as part of the application from
supporting individuals or from a number of recognised
nominating bodies and authorities. Members of each sub-
committee are divided into two approximately equally
sized groups. One half score the bronze applications and
the other half score the other levels. In general, a member
will score all applications for a given level. Some indivi-
duals may occasionally elect not to score a particular appli-
cation, for example, when perceived personal conﬂict of
interest exists. In those circumstances, the mean of the
remaining assessors’ scores is applied to the ‘missing’
assessment. Following secure online submission of scores,
subcommittees meet on two occasions to consider their
scores and the ranking of applicants, considered in the
light of an indicative number of awards suggested to the
subcommittee for each level of award by the main national
committee in advance of the subcommittee meeting. This
indicative number is used to determine a regional
cut-off score against which renewal applications from
the same level are judged. If any uncertainty remains,
individual applicants may be referred for further consid-
eration and re-scoring by a national rescoring (NRES)
committee. Platinum applicants are initially scored
within the subcommittee process, but all are also sec-
ondarily and independently scored by a ‘second-level’
committee constituted at the national level to review
and independently score all applications for this, the
highest level of award. Following consideration at sub-
committee level, a ranked list of recommendations is
made to the central ACCEA committee for further
review and ﬁnal recommendation for funding to the
responsible government minister.
Assessment validity
The validity of assessment is complex, conceptually and
in its evaluation. Downing2 3 summarises validity under
ﬁve headings (content, response process, internal struc-
ture, relationship with other variables and conse-
quences), noting that each component is interlinked
and should not be seen in isolation. In respect of the
ACCEA application process, the domains being assessed
and the criteria adopted for scoring are explicitly
deﬁned in published national guidance for assessors4
and made available within each application (table 1).
The analysis undertaken in this study explores the
internal structure of the assessment process and speciﬁc-
ally its reliability. This is a fundamental component of
an overall evaluation. Derived reliability coefﬁcients
describe the percentage of variability that can be attribu-
ted to true differences between applicants. A coefﬁcient
of 0.8 implies that 80% of the variance in scores
awarded to applicants is attributable to true differences
between the applicants themselves, representing the
‘signal’ that the assessment system is seeking to detect
(the remaining 20% being error—‘noise’—such as
might be attributable to assessor variability for
example). By using variance estimates, modelling can be
undertaken to calculate what would happen to the reli-
ability of the assessment if, for example, applications
were scored by fewer or greater numbers of assessors.5 6
In a time of ﬁnancial austerity and of increased scru-
tiny of spending of public ﬁnances, there is a great need
for evident transparency and streamlining in respect of
resource allocation assessment and distribution. The aim
of this study was to examine the statistical reliability of
the subcommittee assessment process for new applica-
tions received during the 2014 award round and to
provide guidance for the UK ACCEA committee on the
rational use of assessment resources.
MATERIALS AND METHODS
Data were made available on a fully anonymised basis by
the UK Department of Health relating to applications
for national level clinical excellence awards considered
by members of subcommittees plus the scores of the
national committee assessing new platinum level applica-
tions. Data related to assessments made in the 2014
application round; awards from these applications were
made in 2015. Analyses were undertaken in Stata V.13.1
(StataCorp College Station, Texas, USA). All data were
complete apart from the assessor background role for
the national committee assessing new platinum level
applications. The mean score awarded to each applicant
by each assessor was used for all analyses.
ACCEA also administers a parallel, historical scheme
of ‘A’ (gold equivalent) and ‘B’ (bronze equivalent)
award renewal applications whose introduction predated
the present arrangements, which were introduced in
2003. Renewals of historical ‘A’ and ‘B’ awards were
excluded from analysis based on four preliminary
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Table 1 Domains and criteria adopted in the assessment of ACCEA applications
Domain 1—delivering a high quality service Evidence should show achievements in delivering a service which
is safe, has measurably effective clinical outcomes, provides
good patient experience and where opportunities for improvement
are consistently sought and implemented.
0 (Does not meet contractual requirements or when
insufficient information has been produced to make a
judgment.)
2 (Meets contractual requirements) Performance in some aspects of the role could be assessed as
‘over and above’ expected standards. But generally, on the
evidence provided, contractual obligations are fulfilled to
competent standards and no more.
6 (Over and above contractual requirements) Some duties are performed in line with the criteria for ‘Excellent’,
as below. However, on the evidence provided, most are delivered
above contractual requirements, without being in the highest
category.
10 (Excellent) Applicants could show evidence of performance over and above
the standard expected in one or more of the following (this list is
not exhaustive):
▸ Contracted job is carried out to the highest standards.
Evidence for this should come from benchmarking exercises
or objective reviews by outside agencies. Where this is not
available, there should be other evidence that the work
undertaken is outstanding—in relation to service delivery and
outcomes—when compared to that of peers.
▸ Personal role in service delivery by a team, with evidence of
outstanding contribution, such as awards, audits or
publications.
▸ Exemplary standards in dealing with patients, relatives and all
grades of medical and other staff. Applicants should ideally
include reference to a validated patient or carers’ survey or
feedback on the service (external or peer review reports).
Domain 2—developing a high quality service Evidence should show how applicants have significantly
enhanced clinical effectiveness (the quality, safety and
cost-effectiveness) of services locally and more widely within the
NHS if this is the case.
0 (Does not meet contractual requirements or when
insufficient information has been produced to make a
judgement)
2 (Meets contractual requirements) The applicant has fully achieved their service-based goals and
provided comprehensive services to a consistently high level. But
there is no evidence of them making any major enhancements or
improvements.
6 (Over and above contractual requirements) The applicant has made high quality service developments,
improvements or innovations that have contributed to a better and
more effective service delivery. This could be demonstrated by:
▸ Improvement in service based on evidence.
▸ Improved outcomes (clinical effectiveness).
▸ Greater cost-effectiveness.
▸ Services becoming more patient centred and accessible.
▸ Benefits in prevention, diagnosis, treatment or models of care.
For this score, the activity would be expected at local and
possibly regional level—especially if in the face of difficult
circumstances or constraints.
10 (Excellent) In addition to some or all of the achievements listed in 6,
applicants could show evidence of performance over and above
the standard expected in one or more of the following (this is not
exhaustive):
▸ Service innovation—introduction of new procedures,
treatments or service delivery, based on original research or
development or effectively overcoming barriers to clinical
Continued
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Table 1 Continued
effectiveness. This should be backed up by relevant,
completed audit cycles or research that has been adopted at
regional, national or international level, with demonstrable
change in evidence based practice.
▸ Clinical governance—introduction or development of clinical
governance approaches, which have resulted in audited/
published advances taken up elsewhere.
▸ Leadership in the development of the applicant’s specialty at
regional, national or international level. This should include
evidence of wide participation in promoting the development of
evidence-based practice in the specialty, including patient and
public involvement.
Domain 3—leadership and managing a high quality
service
Evidence should show how applicants have made a substantial
personal contribution to leading and managing a local service or
national/international service or health policy development.
0 (Does not meet contractual requirements or when
insufficient information has been produced to make a
judgement)
2 (Meets contractual requirements) Applicants should receive this score if they provide evidence of
successfully contributing to the running of a trust or unit,
especially in difficult circumstances, and maintaining excellent
staff relations—by encouraging colleagues in nursing and other
professionals ancillary to medicine.
6 (Over and above contractual requirements) To score 6 points, applicants must show successful management
skills, especially in innovative development and hard pressed
services. They may also have been involved in recognised
advisory committee work, at area and particularly national level
(especially if as secretary or chair). Other criteria that would merit
this score include effective chairing of a trust or university
committee as, for example, clinical director. Look also for
examples of how applicants have carried out appraisals for peers/
non-career grade doctors or been involved in major reviews,
enquiries or investigations or as part of a College/Specialty
Advisory Committee. ACCEA does not expect to reward
membership of such committees in itself. You should look for
evidence that the contribution made by the applicant has been
over and above expectations.
10 (Excellent) In addition to some achievement acquiring a score of 6,
applicants scoring 10 in this domain will have shown evidence of
outstanding administrative achievement in a leadership role—as
confirmed by their employer and/or other citations. Medical
directors and other clinical managers should not be given this
score purely because they hold the post—there must be clear
evidence that they have distinguished themselves by leadership
in advancement of health policy and delivery.
Other evidence that could merit this score includes (this list is not
exhaustive):
▸ Involvement in shaping national policy, aimed at modernising
health services (might include effective chairing of an area or
national importance advisory committee).
▸ Successful directorship of a large nationally recognised unit,
institute or supraregional services.
▸ Planning and delivery of area or nationwide services.
▸ Other evidence from citations of exceptional activity and
achievement.
Domain 4—research and innovation Evidence should show how applicants have made a contribution
to research or the evidence/evaluative base for quality or service
innovation including the translation of evidence in to practice.
Assessors should note evidence of the impact of research on
improvement in healthcare and health.
Continued
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0 (Does not meet contractual requirements or when
insufficient information has been produced to make a
judgement)
2 (Meets contractual requirements) If the applicant is an academic consultant, they should be
considered by their employer to be ‘research active’—at a level
commensurate with their contract. This rating would be based on
the applicant’s research output and associated publications within
the past 5 years.
If he or she is an NHS consultant, they will have undertaken
clinical research, alone or in collaboration, which has resulted in
publications. Or they may have collaborated actively in basic
research projects established by others. They may also have
actively encouraged research by junior staff and supervised their
work.
6 (Over and above contractual requirements) There will be evidence of the applicant having made a sustained
personal contribution in basic or clinical research which could be
demonstrated by:
▸ A lead or collaborative role, holding, or having held within the
past 5 years, peer reviewed grants.
▸ A role as a major collaborator in clinical trials or other types of
research.
▸ A publication record in peer-reviewed journals within the past
5 years.
▸ Supervision now, or in the past 5 years, of doctorate/
post-doctorate fellows.
▸ Other markers of research standing such as lectures/invited
demonstrations.
▸ Development of a method, a tool or equipment, which
contribute to the understanding of, or towards care delivery.
10 (Excellent) In addition to some or all of the achievements listed in 6,
applicants could show evidence of performance over and above
the standard expected in one or more of the following (this list is
not exhaustive):
▸ Major peer-reviewed grants held currently and/or within the last
5 years, for which the applicant is the principal investigator or
main research lead. They should have included the title,
duration and value.
▸ Contribution to research and the evidence/evaluative base for
quality.
▸ Research publications in high citation journals.
▸ National or international presentations/lectures/demonstrations
given on research.
▸ Supervision of successful doctorate students, some of whom
might have come on national or international fellowships.
▸ Patent of a significant innovation.
▸ Other peer determined markers of research eminence.
Domain 5—teaching and training Evidence should show how teaching and training forms a major
part of the contribution applicants make to the NHS, over and
above contractual obligations.
0 (Does not meet contractual requirements or when
insufficient information has been produced to make a
judgement)
2 (Meets contractual requirements) Evidence of having fulfilled the teaching/training expectations
identified in the job plan, in terms of quality and quantity.
6 (Over and above contractual requirements) Applicants could present evidence in the following areas:
The quality of teaching and/or training through regular audit and
mechanisms such as 360° appraisal. This should include
evidence of adaptation and modification, where appropriate, of
these skills as a result of this feedback.
Continued
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observations: (i) these were all renewal applications, (ii)
the basis on which the award was made was historical
and may have been different from the criteria pertaining
now, (iii) initial analysis showed that ‘A’ renewals were,
on average, much lower scoring than the equivalent
gold renewals and (iv) including these applications (16
in total) would have potential to affect our analysis in an
unpredictable way.
We described the distribution of applications by sub-
committee, between subcommittees and across new and
renewal applications. Since scores had been given on the
basis of the award level applied for (ie, the same applica-
tion assessed for a bronze award would likely score higher
than if assessed for a gold award), all analyses were strati-
ﬁed by award level. We also further stratiﬁed our analysis
by new applications versus renewals, as we would a priori
expect the variance of renewals to be smaller (these appli-
cants previously been judged to meet the minimum stand-
ard and so are likely to be more similar to each other than
new applicants). We quantiﬁed the mean number of
assessments made per applicant, by subcommittee and by
award level. For comparison, we also described the
number of subcommittee members submitting assess-
ments within each committee. The two ‘national’ commit-
tees, assessing applicants from the Department of Health
and the NRES committee, were considered to be regional
subcommittees for analysis purposes. Box plots were used
to illustrate the distribution of scores for each award level
separately for new applications and renewals.
A series of multilevel random intercepts models were
used to estimate the variance components attributable
to four different sources; the subcommittee ðs2RÞ, the
assessors ðs2ASÞ, the applicants ðs2APÞ and residual vari-
ance ðs2eÞ. As applicants received scores from multiple
assessors and assessors score multiple applicants, neither
can be considered to be nested within the other and
rather we consider them to be ‘crossed’.7 Applicants and
assessors are nested within subcommittee, and the
residual variance is nested within applicants and assessors.
The subcommittee variance may either reﬂect systematic
variation in the scores given by different subcommittees
(conditional on the assessors making up those subcom-
mittees) or systematic differences in the mean score of
applicants (ie, the quality of applicants is higher in some
subcommittees than others). Since no assessors and no
applicants sit within more than one subcommittee, it is
impossible to distinguish the relative contribution of
these two components, with the exception of the new plat-
inum applications, which are discussed below. The asses-
sor variance captures systematic differences in the scores
given by different assessors when they have assessed the
same candidates. The applicant variance captures the
true variance between applicants and can be considered
the signal the system is aiming to capture. The residual
variance can be considered noise and can be thought of
as capturing the differences in scores that occur when
assessors, who on average score the same, will give differ-
ent scores to any one candidate. It also captures the possi-
bility that the same assessor may give a different score to
the same candidate at different times.
With the platinum awards, we compare two models,
both including a random effect for subcommittee, but
Table 1 Continued
Involvement in quality assurance of teaching and evidence of
success with regulatory bodies involved with teaching and
training.
High performance in formal roles such as working with under and
postgraduate deans, and involvement with postgraduate
educational programmes in roles such as head of training/
programme director, regional adviser and clinical tutor.
10 (Excellent) In addition to some or all of the achievements listed in 6,
applicants could show evidence of performance over and above
the standard expected in one or more of the following (this list is
not exhaustive):
▸ Leadership and innovation in teaching, including
– new course development
– innovative assessment method
– introduction of new learning techniques
– authorship of successful textbooks or other media on
teaching/training.
▸ National and international educational leadership, such as
presentations, invitations to lecture, peer reviewed and other
publications on educational matters.
▸ Innovation and trend setting in teaching and training, including
examination processes, for a college, faculty, specialist society
or other national professional bodies.
ACCEA, Advisory Committee on Clinical Excellence Awards.
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one based on the subcommittee scores and one based
on the national committee scores. In the later model,
the subcommittee variance relates to the committee
applied to, that is, the region of the candidate rather
than the different committees themselves. Comparing
these two models gives insight into the source of the
committee level variance.
Since judgement about awards are made by subcom-
mittees, which apply speciﬁc regional cut-offs to decide
when awards are recommended (rather than applying
national cut-offs), we estimated reliabilities on the basis
of scores derived within subcommittee rather than as a
part of a national spectrum. In this situation, where all
applicants at a given level are assessed by all of the same
assessors, any variation in the hawkish/dovish tendency
of individual assessors will not affect reliability, as the
same exaggeration/suppression of scores will apply
equally to all candidates within a subcommittee. Thus,
the assessor variance does not inﬂuence reliability (λ)
which is given by:
l ¼ s
2
AP
s2AP þ ðs2e=nÞ
ð1Þ
where n is the number of assessments made per
candidate.
We also estimated the reliability where the make-up of
groups of assessors is not consistent for candidates being
judged against one another, for example as would be
the case if national scoring was used, or not all assessors
within a committee saw all applications being assessed
(see online supplementary material). In this situation,
differences between assessors become important and so
we estimate differences in scores given by assessors of
different background roles and its impact on reliability
(see online supplementary material).
Finally, since the applicants scored by the NRES com-
mittee have already been scored by regional committees
and were considered to be borderline cases, we also
undertook a sensitivity analysis to investigate the contri-
bution of the NRES committee scores to the overall
results. We repeated the models used to estimate the
variance components having excluded the NRES com-
mittee scores.
RESULTS
In 2014, 1916 applications were scored by members of
16 subcommittees (identiﬁed as A-P hereafter). Table 2
shows how these applications were shared between new
applications (1529) and renewals (387) and across the
various awards and subcommittees. New bronze award
applications were the most numerous (650), closely fol-
lowed by new silver applications (614). The smallest
group was gold renewals with only 11 applications. Each
subcommittee scored between 45 and 225 applications.
Figure 1 shows the distribution of scores for new appli-
cations and renewals, stratiﬁed by award level, showing
that the mean score increases with increasing level, as
expected. Further, the renewal scores tend to be higher
than the new scores of the corresponding level. Figure 1
also illustrates the decreasing range of scores with
increasing award level, and smaller range in renewal
applications than that in new applications.
Overall, each application is marked by a mean of 9.5
assessors. Table 3 shows the mean number of assessors
marking each application at each level within each com-
mittee. Typically, the number is between 9.3 and 10.5,
although it does reach as low as 5 for some awards in
one committee. Comparing table 3 with table 4, which
Table 2 Number of applications by subcommittee, level and application type
Regional
subcommittee
New applications Renewals Overall
totalBronze Silver Gold Platinum Total Bronze Silver Gold Platinum Total
A 17 17 6 0 40 9 6 0 1 16 56
B 16 15 3 2 36 7 2 0 0 9 45
C 40 43 9 3 95 28 5 1 2 36 131
D 36 34 12 4 86 9 6 0 1 16 102
E 80 73 27 8 188 26 8 1 2 37 225
F 26 38 13 7 84 12 4 2 2 20 104
G 48 40 14 4 106 27 8 2 5 42 148
H* 33 31 9 0 73 7 1 0 0 8 81
I 29 37 7 2 75 13 5 1 0 19 94
J 37 39 14 2 92 12 6 1 2 21 113
K 77 48 8 4 137 18 7 2 3 30 167
L 17 19 5 0 41 18 2 1 0 21 62
M 50 50 15 1 116 23 6 0 2 31 147
N 49 27 7 0 83 15 2 0 0 17 100
O 39 52 10 3 104 20 7 0 2 29 133
P 56 58 15 2 131 26 7 0 2 35 166
Total 650 621 174 84 1529 270 82 11 24 387 1916
*National rescoring committee (NRES).
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shows the number of assessors making up each commit-
tee, shows that the vast majority of applications were
scored by all committee members. The highest number
of assessors used was 12.
Table 5 shows the estimated variance components of
individual assessor scores of applications attributable to
subcommittee, assessors, participants and residual vari-
ation for each of the award levels and application types.
In each case, the highest variances are either that attrib-
utable to assessors or the residual variance, highlighting
the need for the use of multiple assessors for each appli-
cation. In nearly all cases, the estimated levels of vari-
ance attributable to these two sources are broadly
similar. The exception is for the gold renewals where the
estimates need to be treated with caution due to the
very low sample size. The percentage of total variance
attributable to the applicant decreases from 28% in new
bronze applications to 11% in new platinum applications
scored by the subcommittees. The amount of variance
attributable to the subcommittee is always small (≤4% in
all except gold renewals), and the fact that it is present
in platinum new applications when scored by subcom-
mittees but absent when scored by the national commit-
tee suggests that this variance is attributable to different
subcommittees scoring differently rather than the stand-
ard of candidates varying between subcommittees.
Figure 1 Box plot showing the
variation in applicant scores by
level and application type.
Table 3 Mean number of assessors per application by subcommittee, level and application type
Regional
subcommittee
New applications Renewals
Bronze Silver Gold Platinum Bronze Silver Gold Platinum
A 10.00 12.00 12.00 NA 9.00 12.00 NA 12.00
B 6.00 6.00 5.00 6.00 6.00 6.00 NA NA
C 10.00 8.00 8.00 8.00 9.89 8.00 8.00 8.00
D 8.00 10.00 10.00 8.50 8.00 10.00 NA 10.00
E 11.00 10.96 10.85 10.00 10.00 11.00 11.00 11.00
F 9.00 11.00 11.00 10.00 9.00 11.00 11.00 11.00
G 8.96 8.98 9.00 8.00 8.96 9.00 9.00 9.00
H* 10.00 10.00 9.89 NA 5.00 5.00 NA NA
I 12.00 12.00 12.00 9.50 11.00 12.00 12.00 NA
J 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00
K 10.00 9.98 9.00 9.00 9.00 9.00 10.00 10.00
L 11.00 11.00 10.80 NA 11.00 10.50 10.00 NA
M 8.90 8.96 8.67 8.00 8.91 9.17 NA 8.50
N 10.00 7.00 7.00 NA 10.00 7.00 NA NA
O 9.97 10.00 10.00 8.00 8.00 10.00 NA 10.00
P 10.00 8.98 10.00 10.00 10.00 10.00 NA 10.00
Total 9.83 9.77 9.82 10.50 9.31 9.83 10.09 9.75
*National rescoring committee (NRES).
NA, not available.
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However, the size of this variance is small and the uncer-
tainty is large, and so this interpretation must be treated
with some caution.
In a sensitivity analysis excluding the NRES subcom-
mittee score, we found only minimal changes to the vari-
ance component estimates and so they are not shown. It
is also of note that the variance of mean application
scores observed within the NRES subcommittee was
similar to that observed in the other subcommittees.
Table 6 shows the reliability achieved with a varying
number of assessors in the current situation where the
assessors are kept the same for all applications at a given
level within a particular committee (as judgements are
made within committee, in this scenario the assessor
variance and subcommittee variance are not considered
important). The number of assessors required to reach
various reliability thresholds is shown in table 7, where it
is evident that the assessment of new bronze applications
could attain a reliability of 0.9 with 12 assessors per com-
mittee; other levels would only reach around 0.8 with
similar numbers of assessors.
Varying the make-up of groups of assessors such that
they are not consistent for candidates being judged
against one another substantially increases the number
of assessors needed to reach the same levels of reliability
compared to the current situation (see online
supplementary material). While there was some evi-
dence that assessors from different background roles
gave systematically different scores, adjusting for this had
no appreciable impact on reliability (see online
supplementary material).
DISCUSSION
We have outlined, for the ﬁrst time, the evidence-base in
respect of the assessment process applied to applications
Table 4 Number of assessors on each subcommittee
committee
Regional
subcommittee Bronze
Silver/gold/
platinum Total
A 10 12 22
B 6 6 12
C 10 8 18
D 8 10 18
E 11 11 22
F 9 11 20
G 9 9 18
H* 10 10 20
I 12 12 24
J 10 10 20
K 10 10 20
L 11 11 22
M 9 10 19
N 10 7 17
O 10 10 20
P 10 10 20
*National rescoring committee (NRES).
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by senior clinicians for a clinical excellence award.
These awards are prestigious, and highly competed for,
with only around 15% of NHS consultants or senior aca-
demic general practitioners holding such an award
during their lifetime. The awards themselves are of sig-
niﬁcant monetary value, estimated to total £160 m (US
$230 m) across the NHS in 2015–2016, and it is of
importance that the assessment process should be trans-
parent and reliable.
We explored the ACCEA awards process operated in
the 2014 round of applications. Nearly 2000 applications
were submitted. In each centre, between 6 and 12 asses-
sors were used to make an overall judgement about the
suitability of each award. The same scoring scale was
used across each award level. The validity of the assess-
ment process was therefore suggested by a predictable
increase in scores across the four award grades, evident
for new and renewal applications.
This study has identiﬁed that reliable assessments
(>0.7) of bronze applications can be attained by using
just 4 assessors, in contrast with the average of around
10 assessors used across the whole sample. Reliability
can be increased by increasing the number of assessors;
for example, in assessing bronze-level applications,
reliability of 0.8 and 0.9 can be attained through the use
of 6 and 12 assessors, respectively. The decision regard-
ing the appropriate level of reliability to adopt is ultim-
ately pragmatic, being based on the number of available
assessors, given the present structures and resources
within which the assessment process operates. A thresh-
old of 0.9 for reliability may be judged appropriate for
some ‘high stakes’ assessments such as in ﬁnal medical
examinations.8 While it might be argued that a some-
what lower threshold for reliability would also be defens-
ible in settings such as we describe here, given the
nature and purpose of the awards, we would advise that
a reliability threshold of at least 0.8 be adopted where
possible.
Strengths and limitations
The main strength of the study is that it used compre-
hensive national data drawn from all of the 16 subcom-
mittees assessing applications in the UK. Furthermore,
we have used a modelling approach that quantiﬁes var-
iances from a number of sources. A limitation of our
analysis is that we assume the assessor variance to be
constant across different types of assessor. We are unable
to determine empirically if this assumption is reasonable
Table 6 Reliability achieved using differing numbers of assessors in the current situation where the make-up of committee is
constant for all assessments of one type within a subcommittee, by level and application type
Number of
assessors
Reliability
New applications Renewals
Bronze Silver Gold
Platinum
(regional
subcommittee
Platinum
(national
committee) Bronze Silver Gold
Platinum
(regional
subcommittee)
1 0.44 0.32 0.25 0.23 0.32 0.34 0.32 0.32 0.10
2 0.61 0.49 0.40 0.37 0.48 0.51 0.48 0.49 0.19
3 0.70 0.59 0.50 0.47 0.58 0.61 0.58 0.59 0.26
4 0.76 0.65 0.57 0.54 0.65 0.67 0.65 0.65 0.32
5 0.80 0.70 0.62 0.59 0.70 0.72 0.70 0.70 0.37
6 0.82 0.74 0.67 0.64 0.74 0.76 0.74 0.74 0.41
7 0.84 0.77 0.70 0.67 0.76 0.78 0.77 0.77 0.45
8 0.86 0.79 0.73 0.70 0.79 0.81 0.79 0.79 0.48
9 0.87 0.81 0.75 0.72 0.81 0.82 0.81 0.81 0.51
10 0.89 0.83 0.77 0.74 0.82 0.84 0.82 0.83 0.54
11 0.90 0.84 0.78 0.76 0.84 0.85 0.84 0.84 0.56
12 0.90 0.85 0.80 0.78 0.85 0.86 0.85 0.85 0.58
Table 7 Numbers of assessors required to reach various reliability thresholds in the current situation where the make-up of
committee remains static for all assessments of one type within a subcommittee, by level and application type
New applications Renewals
Reliability Bronze Silver Gold
Platinum (regional
subcommittee)
Platinum
(national
committee) Bronze Silver Gold
Platinum (regional
subcommittee)
0.7 4 5 8 8 6 5 5 4 20
0.8 6 9 13 14 9 8 9 9 35
0.9 12 20 28 31 20 18 20 20 78
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owing to a lack of statistical power, but we have no
reason to suspect that it is an unreasonable assumption.
We also assume that the assessor variances are constant
across committees, and while there is some evidence
that a committee made up of more experienced asses-
sors are more consistent, this is unlikely to have a large
impact on our ﬁndings as regional committees all
contain a range of experience in their assessors.
It is, perhaps, not surprising that reliability is harder
to achieve among higher level award applicants and
among applicants for renewal of awards. This is primar-
ily because such individuals tend to be more ‘similar’ in
proﬁle, harder to differentiate and thus require larger
numbers of assessors. Thus, achieving reliability >0.8 in
the assessment of new gold or platinum applications
requires 13 and 14 assessors, respectively, although reli-
ability of this level can be attained in scoring by 9 asses-
sors in a national platinum subcommittee (the national
platinum subcommittee currently involves around 28
assessors, well in excess of what is actually required).
Members of this latter subcommittee are drawn from
around 28 experienced, senior members of all of the
subcommittees, and their experience may result in more
consistent scoring, in turn accounting for the greater
reliability observed following scoring by these assessors.
At its most extreme, scoring by 78 experienced indivi-
duals is required to attain reliability >0.9 in the assess-
ment of platinum renewal applications—an assessor
quotient unlikely to be achievable within the present
scoring structures.
An alternative approach to improving reliability is to
consider that the scoring system may be insufﬁciently
sensitive to detect differences between applicants, espe-
cially differences among those applying for higher level
awards. Taking the example of platinum applications,
for which the vast majority of scores are either ‘excel-
lent’ contributions (scoring 10) and ‘over and above
contractual requirement’ (scoring 6), the scoring system
allows little room for differentiation between the very
best applicants. It is interesting to note that the national
committee do seem to use the instrument in a more dis-
criminating way, but potentially still not good enough to
attain a reliability threshold of 0.9. In these circum-
stances, one option to consider would be the design of a
more sensitive instrument, perhaps involving the more
accurate deﬁnition of performance at each of the
scoring threshold, or perhaps offering more scoring
options to allow greater discrimination. In addition, and
importantly, training of all assessors is likely to result in
improved overall reliability of the assessment process.
Despite being resourced by the most experienced
assessors, we observed that assessments undertaken by
NRES had similar variance to that seen in other subcom-
mittees. Theoretically, one would anticipate that the add-
itional experience of assessors would result in greater
reliability of assessments. On reﬂection however, our
observation is not surprising, since applications consid-
ered by NRES are likely to be rather similar to other
applications made at the same level being considered by
NRES, since all may be considered ‘borderline’—this
being the basis for referrals to NRES. The greater poten-
tial reliability offered by experience of assessors thus
appears to be offset by the greater similarity among
those being assessed, accounting for the observed simi-
larity in variance.
In the current situation, where all assessors score all
applicants for a given level within a subcommittee, the
make-up is standard for all applicants within that assessor
scoring group. Owing to this, there is no gain to be made
by standardising committee make-up in terms of assessor
background role. In theory, it may help in the situation
where comparisons are made between applicants scored
by different assessors (such as using a national threshold
for award), but the improvements are negligible com-
pared to the dramatic reduction in reliability this recon-
ﬁguration would incur. Given the observed patterns of
scoring and reliability, consideration should be given
to splitting the subcommittee unequally with a view to
ensuring that larger numbers of assessors are allocated
to score applications above the bronze level. Thus, a
subcommittee of 22 people might allocate 8 assessors
to the assessment of bronze-level applications, and 14
individuals to the remaining applications.
CONCLUSIONS
Assessment processes pertaining in the competitive alloca-
tion of public funds need to be credible and efﬁcient. The
present arrangements for assessing and scoring applica-
tions are defensible, depending on the level of reliability
judged to be required in the assessment process. Our data
suggest that some relatively minor reconﬁguration in
approaches to scoring might usefully be considered to
further reﬁne and optimise the use of available resources
deployed in the assessment of these prestigious awards.
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